ESC Textbook of Cardiovascular Imaging - sample
Discover the ESC Textbook of Cardiovascular Imaging 2nd edition
Discover the ESC Textbook of Cardiovascular Imaging 2nd edition
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
myocardial viability 363–4, 381–94<br />
myocarditis 476, 539–47<br />
myxoma 551<br />
navigator-echo 57<br />
neuromuscular disorders 480–1<br />
papillary fibroelastoma 552<br />
parallel imaging 56<br />
patent ductus arteriosus 591<br />
pericardial effusion 515–16<br />
peripartum cardiomyopathy 482<br />
phase-contrast flow quantification 60<br />
phase-sensitive inversion-recovery 59<br />
physics <strong>of</strong> 55<br />
prospective triggering 56<br />
prosthetic valve function 194<br />
pulmonary hypertension 597<br />
pulmonary regurgitation 181<br />
pulmonary stenosis 177<br />
pulmonary valve 174–5<br />
pulmonary venous flow 328<br />
pulse sequences 56<br />
radi<strong>of</strong>requency catheter ablation 109–11<br />
Rastelli procedure 595<br />
repaired tetralogy <strong>of</strong> Fallot 594<br />
respiratory motion 57<br />
rhabdomyoma 554<br />
right ventricular ejection fraction 437<br />
right ventricular function 348<br />
right ventricular outflow tract<br />
obstruction 592<br />
Ross operation 593<br />
sarcoidosis 462–3, 477–8<br />
sarcomas 555<br />
Senning operation 595<br />
spatial encoding 55<br />
spin-echo 56<br />
T1 55<br />
T1 mapping 107–9, 460–1, 465, 482<br />
T1 scout sequence 59, 391<br />
T2 55<br />
T2* 58<br />
Takotsubo cardiomyopathy 484, 502<br />
TAVI 207<br />
tetralogy <strong>of</strong> Fallot 578<br />
3D acquisition 59, 297<br />
thrombus 559<br />
transposition <strong>of</strong> the great arteries 595<br />
tricuspid regurgitation 180, 593–4<br />
tricuspid stenosis 175<br />
tricuspid valve 174–5<br />
turbo-spin echo 56<br />
2D sequences 59<br />
velocity-encoded 60, see velocity-encoded<br />
CMR<br />
ventricular septal defects 590<br />
cardiac masses, differential diagnosis 549;<br />
see also cardiac tumours<br />
cardiac metastases 549, 556–9<br />
cardiac myxoma 550–1<br />
cardiac resynchronization therapy<br />
candidate selection 405–17<br />
cardiac innervation imaging 401<br />
follow-up 424–9<br />
integrative evaluation approach 416–17<br />
left ventricular diastolic function 427<br />
left ventricular dyssynchrony 406–12<br />
left ventricular reverse modelling 424–6,<br />
427–9<br />
mitral regurgitation 427<br />
myocardial scar 414–16<br />
optimization 125, 420–4<br />
right ventricular function 427<br />
super-responders 426<br />
venous anatomy 413–14<br />
cardiac rhabdomyoma 554<br />
cardiac sarcomas 555<br />
cardiac tamponade 440, 510, 513, 515, 516<br />
cardiac tumours<br />
angiosarcoma 555<br />
fibroma 554–5<br />
haemangioma 553–4<br />
lipoma 553<br />
lymphoma 555–6, 557<br />
metastatic 549, 556–9<br />
myxoma 550–1<br />
papillary fibroelastoma 551–2<br />
primary 549–56<br />
rhabdomyoma 554<br />
sarcomas 555<br />
secondary 549, 556–9<br />
cardiotoxic agents 481–2<br />
Carillon Mitral Contour System 215<br />
Carpentier’s classification 158, 211<br />
catheter ablation 109–11, 124–5<br />
catheterization laboratory procedures 116–23<br />
Chagas’ disease 478–9<br />
chest pain 275–6<br />
chest X-ray<br />
adult congenital heart disease 565<br />
constrictive pericarditis 524<br />
pericardial effusion 510–11<br />
pericardiocentesis 518<br />
cholesterol 303, 304<br />
chordae tendinae 158<br />
Churg–Strauss syndrome 479<br />
cinefluoroscopy 189, 193, 200<br />
circumferential uniformity ratio estimate<br />
(CURE) 411<br />
11<br />
C-labelled tracers 41–2<br />
coarctation <strong>of</strong> the aorta 571–2, 591, 618<br />
collagen volume fraction 104<br />
colour Doppler imaging<br />
aortic regurgitation 143<br />
data acquisition 77<br />
hypertrophic cardiomyopathy 447, 449–50<br />
mitral regurgitation 163<br />
myocardial function 78–80<br />
post-processing 78<br />
right ventricular systolic function 345<br />
3D 69<br />
common arterial trunk 595<br />
congenitally corrected transposition <strong>of</strong> the great<br />
arteries 580–1, 595<br />
congestive heart failure 318–19<br />
constrictive pericarditis 520–34<br />
effusive 533–4<br />
history 523–4<br />
Kussmaul’s sign 522, 524<br />
non-invasive imaging 524–33<br />
pathophysiology 520–3<br />
physical examination 524<br />
regional 534<br />
septal bouncing 522, 525, 532<br />
transient 534<br />
without pericardial thickening 534<br />
continuity equation 74, 132–3, 149, 188<br />
continuous wave Doppler<br />
aortic regurgitation 144–5<br />
coarctation <strong>of</strong> the aorta 571–2<br />
hypertrophic cardiomyopathy 450<br />
isovolumic relaxation time 325<br />
left ventricular diastolic function 325–6<br />
measurements 31<br />
mitral regurgitation 166<br />
index 641<br />
right ventricular outflow tract obstruction 573<br />
tricuspid stenosis 175<br />
contractile reserve 133<br />
contraction front map 72<br />
contrast-enhanced MR angiography 612, 614,<br />
615, 616, 618<br />
contrast enhanced MRI, see late gadolinium<br />
enhanced CMR<br />
Cormier score 152<br />
coronary artery bypass grafts 276<br />
coronary artery disease<br />
adult congenital heart disease 597<br />
cardiac innervation imaging 397<br />
CMR 61, 286–98<br />
coronary calcium scoring 263–4, 277–8, 280<br />
CT coronary angiography 101, 103–5, 271–7<br />
detection by echocardiography 247–55<br />
hybrid imaging 95–6<br />
myocardial dysfunction 352–3<br />
nuclear cardiology 258–68<br />
pre-test likelihood <strong>of</strong> 259<br />
spectrum 258<br />
vulnerable atherosclerotic plaques 302–9<br />
coronary artery stents 276–7<br />
coronary calcium scoring 263–4, 277–8, 280<br />
coronary flow reserve 247, 251–4<br />
cor triatriatum sinister 594<br />
CT coronary angiography<br />
accuracy 272–5<br />
acute chest pain 275–6<br />
appropriateness criteria 281<br />
atherosclerotic plaques 104, 277–80, 304–5<br />
bypass grafts and stents 276–7<br />
coronary artery disease 101, 103–5, 271–7<br />
data interpretation 272<br />
ECG-gating 272<br />
hybrid imaging 93–4, 95–6<br />
image evaluation 52–3<br />
iodine contrast 305<br />
ischaemia 277<br />
limitations 53, 90<br />
multi-vessel disease 96<br />
pre-medication 272<br />
prerequisites 272<br />
radiation dose 95<br />
retrospective gating 49–50<br />
D<br />
Danon disease 465<br />
dead time 37<br />
De Bakey classification 606<br />
deformation imaging 77–85<br />
hypertrophic cardiomyopathy 451<br />
left ventricular architecture 77<br />
left ventricular diastolic function 327<br />
left ventricular regional systolic<br />
function 316–17<br />
delayed contrast enhancement, see late<br />
gadolinium enhanced CMR<br />
diabetes mellitus 402<br />
diastolic stress test 331<br />
diastolic wall strain 331<br />
dilated cardiomyopathy 468–85<br />
aetiology 469<br />
cardiotoxic drugs 481–2<br />
Chagas’ disease 478–9<br />
definition 468<br />
familial 469<br />
idiopathic 469–75<br />
isolated left ventricular non-compaction 482–4<br />
left ventricular dysfunction 468–9<br />
myocarditis 475–6